欢迎您加入月均活跃用户100万＋的科研社区！如您有任何系统建议，请；如有合作推广需求，请点此洽谈。
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI？是时候来Springer出书了！ |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Journal of Thoracic Oncology J THORAC ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.2
50人评分
我要评分
声誉 9.9 影响力 8.6 速度 9.4 | |||||||||||||||||||||||||||||||
| 期刊ISSN | 1556-0864 | 
蝌蝌APP，让您与同行交流更轻松
 立即下载 | ||||||||||||||||||||||||||||||
| E-ISSN | 1556-1380 | |||||||||||||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 20.8 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
| 实时影响因子 | 截止2025年5月19日：20.347 | |||||||||||||||||||||||||||||||
| 2024-2025自引率 | 3.40%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
| 五年影响因子 | 18.4 | |||||||||||||||||||||||||||||||
| JCI期刊引文指标 | 4.24 | |||||||||||||||||||||||||||||||
| h-index | 113 | |||||||||||||||||||||||||||||||
| CiteScore （ 2025年最新版） |
| |||||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||||
| 期刊官方网站 | http://www.jto.org/ | |||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/JTO | |||||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Journal of Thoracic Oncology的语言要求，还能让Journal of Thoracic Oncology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Journal of Thoracic Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||||||||
| 通讯方式 | LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621 | |||||||||||||||||||||||||||||||
| 出版商 | International Association for the Study of Lung Cancer | |||||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-呼吸系统 | |||||||||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||||||||
| 出版年份 | 2006 | |||||||||||||||||||||||||||||||
| 年文章数 | 100点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
| Gold OA文章占比 | 36.90% | |||||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 92.00% | |||||||||||||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||||||||
| 中国科学院《国际期刊预警 名单（试行）》名单 | 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||||
| 中国科学院期刊分区 （ 2025年3月最新升级版） | 点击查看中国科学院期刊分区趋势图
| |||||||||||||||||||||||||||||||
| 中国科学院期刊分区 （ 2023年12月升级版） |
| |||||||||||||||||||||||||||||||
| 中国科学院期刊分区 （ 2022年12月旧的升级版） |
| |||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1556-0864%5BISSN%5D | |||||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 一般,3-6周 | |||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较易 | |||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Journal of Thoracic Oncology顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Safety, Efficacy, and Biomarker Analysis of Deulorlatinib (TGRX-326) in Anaplastic Lymphoma Kinase-Positive NSCLC: A Multicenter, Open-Label, Phase 1/1b Trial Author: Zhao, Shen; Zhou, Huaqiang; Yang, Nong; Wang, Zhehai; Jin, Wenjian; Ma, Yuxiang; Xue, Jinhui; Li, Xingya; Liu, Yunpeng; Meng, Rui; Zhou, Jianying; Cheng, Ying; Wang, Yongsheng; Yu, Zhuang; Cao, Yu; Zhao, Yuanyuan; Huang, Yan; Fang, Wenfeng; Zhang, Yang; Hong, Shaodong; Wu, Bo; Shi, Yanxia; Cao, Jingrong; Xu, Mingyan; Zhang, Xiaoni; Hu, Longyu; Peng, Bo; Yang, Yunpeng; Zhang, Li; Zhao, Hongyun Journal: JOURNAL OF THORACIC ONCOLOGY. 2025; Vol. 20, Issue 6, pp. 750-762. DOI: 10.1016/j.jtho.2024.11.010 PubMed DOI |
| 2. | Refining Surgical Decision-Making for Elderly Patients With Lung Cancer: Recognized Risks, Unmet Needs Author: Wang, Feng; Bao, Minwei; Zhu, Lei Journal: JOURNAL OF THORACIC ONCOLOGY. 2025; Vol. 20, Issue 5, pp. e62-e63. DOI: 10.1016/j.jtho.2025.02.008 PubMed DOI |
| 3. | Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A Author: Besse, Benjamin; Goto, Koichi; Wang, Yongsheng; Lee, Se-Hoon; Marmarelis, Melina E.; Ohe, Yuichiro; Bernabe, Reyes; Kim, Dong-Wan; Lee, Jong-Seok; Cousin, Sophie; Ichihara, Eiki; Li, Yongsheng; Paz-Ares, Luis; Ono, Akira; Sanborn, Rachel E.; Watanabe, Naohiro; de Miguel, Maria Jose; Helissey, Carole; Shu, Catherine A.; Spira, Alexander I.; Tomasini, Pascale; Yang, James Chih-Hsin; Zhang, Yiping; Felip, Enriqueta; Griesinger, Frank; Waqar, Saiama N.; Calles, Antonio; Neal, Joel W.; Baik, Christina S.; Jaenne, Pasi A.; Shreeve, S. Martin; Curtin, Joshua C.; Patel, Bharvin; Gormley, Michael; Lyu, Xuesong; Chen, Jun; Chu, Pei-Ling; Mahoney, Janine; Trani, Leonardo; Bauml, Joshua M.; Thayu, Meena; Knoblauch, Roland E.; Cho, Byoung Chul Journal: JOURNAL OF THORACIC ONCOLOGY. 2025; Vol. 20, Issue 5, pp. 651-664. DOI: 10.1016/j.jtho.2024.12.029 PubMed DOI |
| 4. | Polygenic Risk Score and Lung Adenocarcinoma Risk Among Never-Smokers by EGFR Mutation Status: A Brief Report Author: Blechter, Batel; Hsiung, Chao Agnes; Wang, Xiaoyu; Zhang, Haoyu; Seow, Wei Jie; Shi, Jianxin; Chatterjee, Nilanjan; Kim, Hee Nam; Wong, Maria Pik; Hong, Yun-Chul; Wong, Jason Y. Y.; Dai, Juncheng; Hosgood, H. Dean; Wang, Zhaoming; Chang, I-Shou; Choi, Jiyeon; Wang, Jiucun; Song, Minsun; Hu, Wei; Zheng, Wei; Kim, Jin Hee; Zhou, Baosen; Albanes, Demetrius; Shin, Min-Ho; Chung, Lap Ping; An, She-Juan; Zheng, Hong; Yatabe, Yasushi; Zhang, Xu-Chao; Kim, Young Tae; Shu, Xiao-Ou; Kim, Young-Chul; Vermeulen, Roel C. H.; Bassig, Bryan A.; Chang, Jiang; Ho, James Chung Man; Ji, Bu-Tian; Kubo, Michiaki; Daigo, Yataro; Momozawa, Yukihide; Kamatani, Yoichiro; Honda, Takayuki; Kunitoh, Hideo; Watanabe, Shun-ichi; Miyagi, Yohei; Nakayama, Haruhiko; Matsumoto, Shingo; Tsuboi, Masahiro; Goto, Koichi; Yin, Zhihua; Takahashi, Atsushi; Goto, Akiteru; Minamiya, Yoshihiro; Shimizu, Kimihiro; Tanaka, Kazumi; Wu, Tangchun; Wei, Fusheng; Su, Jian; Kim, Yeul Hong; Oh, In-Jae; Lee, Victor Ho Fun; Su, Wu-Chou; Chen, Yuh-Min; Chang, Gee-Chen; Chen, Kuan-Yu; Huang, Ming-Shyan; Lin, Hsien-Chih; Seow, Adeline; Park, Jae Yong; Kweon, Sun-Seog; Chen, Chien-Jen; Gao, Yu-Tang; Wu, Chen; Qian, Biyun; Lu, Daru; Liu, Jianjun; Jeon, Hyo-Sung; Hsiao, Chin-Fu; Sung, Jae Sook; Tsai, Ying-Huang; Jung, Yoo Jin; Guo, Huan; Hu, Zhibin; Chen, Tzu-Yu; Burdett, Laurie; Yeager, Meredith; Hutchinson, Amy; Berndt, Sonja I.; Wu, Wei; Wang, Junwen; Choi, Jin Eun; Park, Kyong Hwa; Sung, Sook Whan; Liu, Li; Kang, Chang Hyun; Chen, Chung-Hsing; Xu, Jun; Guan, Peng; Tan, Wen; Wang, Chih-Liang; Sihoe, Alan Dart Loon; Chen, Ying; Choi, Yi Young; Kim, Jun Suk; Yoon, Ho-Il; Cai, Qiuyin; Park, In Kyu; Xu, Ping; He, Qincheng; Chen, Chih-Yi; Wu, Junjie; Lim, Wei-Yen; Chen, Kun-Chieh; Chan, John K. C.; Li, Jihua; Chen, Hongyan; Yu, Chong-Jen; Jin, Li; Fraumeni, Joseph F., Jr.; Liu, Jie; Landi, Maria Teresa; Yamaji, Taiki; Yang, Yang; Hicks, Belynda; Wyatt, Kathleen; Li, Shengchao A.; Ma, Hongxia; Song, Bao; Wang, Zhehai; Cheng, Sensen; Li, Xuelian; Ren, Yangwu; Iwasaki, Motoki; Zhu, Junjie; Jiang, Gening; Fei, Ke; Wu, Guoping; Chien, Li-Hsin; Tsai, Fang-Yu; Yu, Jinming; Stevens, Victoria L.; Yang, Pan-Chyr; Lin, Dongxin; Chen, Kexin; Wu, Yi-Long; Matsuo, Keitaro; Rothman, Nathaniel; Shiraishi, Kouya; Shen, Hongbing; Chanock, Stephen J.; Kohno, Takashi; Lan, Qing Journal: JOURNAL OF THORACIC ONCOLOGY. 2025; Vol. 20, Issue 4, pp. 521-530. DOI: 10.1016/j.jtho.2024.11.019 PubMed DOI |
| 5. | Limited Predictive Value of Incidental Pulmonary Nodules for NSCLC Cancer Mortality Author: Yang, Jia; Wang, Zuoyun Journal: JOURNAL OF THORACIC ONCOLOGY. 2025; Vol. 20, Issue 4, pp. e56-e57. DOI: 10.1016/j.jtho.2024.12.008 PubMed DOI |
| 6. | Receptor Tyrosine Kinase Fusion-Mediated Resistance to EGFR TKI in EGFR-Mutant NSCLC: A Multi-Center Analysis and Literature Review Author: Xia, Yang; Wang, Kaiwen; Zhao, Jing; Arter, Zhaohui; Zhang, Yongchang; Zhou, Jiaqi; Lu, Yuefei; Zeng, Liang; Du, Robyn; Owens, Jennifer A.; Elamin, Yasir Y.; Gay, Carl M.; Skoulidis, Ferdinandos; Tsao, Anne S.; Lu, Charles; Cascone, Tina; Gibbons, Don L.; Zhang, Jianjun; Chen, Olivia; Mok, Kevin K. S.; Nagasaka, Misako; Li, Wen; Heymach, John, V; Ignatius, Sai-Hong; Li, Molly; Le, Xiuning Journal: JOURNAL OF THORACIC ONCOLOGY. 2025; Vol. 20, Issue 4, pp. 465-474. DOI: 10.1016/j.jtho.2024.11.027 PubMed DOI |
| 7. | RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC Author: Nakagawa, Kazuhiko; Garon, Edward B.; Seto, Takashi; Nishio, Makoto; Aix, Santiago Ponce; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Nishino, Kazumi; Yoh, Kiyotaka; Shih, Jin-Yuan; Chik, Jeannie Y. K.; Moro-Sibilot, Denis; Puri, Tarun; Varughese, Sunoj Chacko; Frimodt-Moller, Bente; Visseren-Grul, Carla; Reck, Martin Journal: JOURNAL OF THORACIC ONCOLOGY. 2025; Vol. 20, Issue 4, pp. 487-499. DOI: 10.1016/j.jtho.2024.11.032 PubMed DOI |
| 8. | Characterization of Mutated KRAS Genotype and Clinical Outcomes in Patients With Advanced NSCLC Treated With Mecbotamab Vedotin, a CAB-AXL-ADC Author: Rotow, Julia; Dy, Grace K.; Yau, Edwin; Shum, Elaine; Alexander, Mariam; Reckamp, Karen L.; Leung, Roland; Kowalski, Dariusz M.; Pradera, Jose Fuentes; Fraile, Jon Zugazagoitia; Chen, Kyechin; Aysola, Kartik; Camidge, D. Ross Journal: JOURNAL OF THORACIC ONCOLOGY. 2025; Vol. 20, Issue 4, pp. S3-S4. DOI: |
| 9. | Safety and necessity of mediastinal lymph nodes dissection omission following nodal clearance with neoadjuvant immunochemotherapy in cN0/N1 non-small cell lung cancer Author: Zhou, Y.; Long, H.; Lin, Y.; Zhai, W-y Journal: JOURNAL OF THORACIC ONCOLOGY. 2025; Vol. 20, Issue 3, pp. -. DOI: |
| 10. | Four-year outcomes with perioperative toripalimab plus chemotherapy in resectable stage III non-small cell lung cancer (NeoTAP01 study) Author: Zhou, Y.; Long, H.; Zhao, Z-R.; Lin, Y.; Sun, W.; Feng, S-C Journal: JOURNAL OF THORACIC ONCOLOGY. 2025; Vol. 20, Issue 3, pp. -. DOI: |
|
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
